European Medicines Agency receives 1,000th application for a Paediatric Investigation Plan or Waiver
08/10/2010 - The European Medicines Agency has received and validated the 1,000th application for a Paediatric Investigation Plan (PIP) or Waiver since its Paediatric Committee was established in July 2007.
The workload of the Committee has been high from the outset, and has increased over its three years of operation. To date, more than 450 PIPs and Waivers have received a positive opinion from the Committee. Opinions from the Paediatric Committee are followed by Decisions signed by the Agency's Executive Director, Thomas Lönngren.
The Agency thanks the members and alternates of the Committee, as well as Agency staff, for their dedication and hard work in helping the Agency to meet its legal obligations towards improving medicines for children.